| Pharmaceutical active ingredients: |
| Diclofenac Sodium |
| Available forms, composition and doses of Voltarene: |
| Injectable; Injection; Diclofenac Sodium 25 mg / mlSolution; Ophthalmic; Diclofenac Sodium 0.1%Suppositories; Rectal; Diclofenac Sodium 100 mgSuppositories; Rectal; Diclofenac Sodium 25 mgTablets, Gastro-Resistant; Oral; Diclofenac Sodium 25 mgTablets, Gastro-Resistant; Oral; Diclofenac Sodium 50 mgTablets, Prolonged Release; Oral; Diclofenac Sodium 100 mg |
| Voltarene medical category: |
| Human:Analgesics (non-opioid) and antipyreticsCyclooxygenase-2 (COX-2) inhibitorsNonsteroidal antiimflammatory agentsDermatologicalsMouth / throat preparationsNonsteroidal anti-inflammatory drugs (NSAIDs)Ophthalmic decongestants, anesthetics, anti-inflammatories |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| M01AB05 - Diclofenac |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novartis |
| Related documents and information about Voltarene: |
| Voltaren prescribing information (PDF)Voltaren Gel prescribing information (PDF)Voltaren Ophthalmic prescribing information (PDF)Voltaren-XR prescribing information (PDF)Voltaren medication guide (PDF) |